1 December 2025 - Health Canada's Pharmaceutical Drugs Directorate and the US FDA Office of Generic Drugs have created a program to support the establishment of a request for information sharing program.
This is a critical advancement in international collaboration. It falls under the framework of the generic drug cluster and through the confidentiality commitments established between Health Canada and FDA.